The soluble VEGFR1 concentration in the serum of patients with colorectal cancer

被引：0
|
作者：
Oranus Abbasi
Farhad Mashayekhi
Ebrahim Mirzajani
Saba Fakhriyeh Asl
Touraj Mahmoudi
Hamid Saeedi Saedi
机构：
[1] University of Guilan,Department of Cell and Molecular Biology, Pardis International
[2] University of Guilan,Department of Biology, Faculty of Sciences
[3] Guilan University of Medical Sciences,Cellular and Molecular Research Center, Faculty of Medicine
[4] Guilan University of Medical Science,Division of Gastroenterology and Liver Disease, Gastric and Liver Disease Research Center
[5] Shahid Beheshti University of Medical Sciences,Gastroenterology and Liver Diseases Research Center
[6] Guilan University of Medical Sciences,Razi Hospital
来源：
Surgery Today | 2015年 / 45卷
关键词：
Soluble VEGFR1; Colorectal cancer; Ectodomain shedding; Serum;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：215 / 220
页数：5
相关论文
共 50 条
  • [41] Extracellular Granzyme K Modulates Angiogenesis by Regulating Soluble VEGFR1 Release From Endothelial Cells
    Li, Shuang
    van Dijk, Christian G. M.
    Meeldijk, Jan
    Kok, Helena M.
    Blommestein, Isabelle
    Verbakel, Annick L. F.
    Kotte, Marit
    Broekhuizen, Roel
    Lacle, Miangela M.
    Goldschmeding, Roel
    Cheng, Caroline
    Bovenschen, Niels
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [42] Immunolocalization of VEGF A and Its Receptors, VEGFR1 and VEGFR2, in the Liver From Patients With Biliary Atresia
    Edom, Patricia Turnes
    Meurer, Luise
    da Silveira, Themis Reverbel
    Matte, Ursula
    dos Santos, Jorge Luiz
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2011, 19 (04) : 360 - 368
  • [43] AUTOANTIBODIES AGAINST THE EGF/EGFR AND VEGFA/VEGFR1 ARE PROGNOSTIC BIOMARKERS IN PRIMARY EPITHELIAL OVARIAN CANCER PATIENTS
    Braicu, E.
    Dachend, R.
    Dragun, D.
    Busjahn, A.
    Chekerov, R.
    Heidecke, H.
    Sehouli, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 337 - 337
  • [44] Diagnostic significance of serum pentraxin 3 concentration in colorectal cancer patients
    Zajkowska, M.
    Safiejko, K.
    Juchimiuk, M.
    Kulczynska-Przybik, A.
    Gudowska-Sawczuk, M.
    Mroczko, B.
    CLINICA CHIMICA ACTA, 2024, 558 : 24 - 24
  • [45] Positive and Negative Modulation of Angiogenesis by VEGFR1 Ligands
    Cao, Yihai
    SCIENCE SIGNALING, 2009, 2 (59) : re1
  • [46] On the relationship of LDL and VEGFR1: not just a family affair
    Yla-Herttuala, Seppo
    Alitalo, Kari
    EMBO REPORTS, 2007, 8 (12) : 1127 - 1128
  • [47] Neutrophil Expression of ICAM1, CXCR1, and VEGFR1 in Patients with Breast Cancer Before and After Adjuvant Chemotherapy
    Lohri, Corinne
    Schaltegger, Claudia S. Hutzli
    Van den Broek, Maries
    Wenger, Roland H.
    Ruegg, Curzio
    Fink, Daniel
    Fehr, Mathias K.
    Knuth, Alexander
    Zweifel, Martin
    ANTICANCER RESEARCH, 2014, 34 (09) : 4693 - 4699
  • [48] VEGF-A, VEGFR1 and VEGFR2 single nucleotide polymorphisms and outcomes from the AGITG MAX trial of capecitabine, bevacizumab and mitomycin C in metastatic colorectal cancer
    Chionh, Fiona
    Gebski, Val
    Al-Obaidi, Sheren J.
    Mooi, Jennifer K.
    Bruhn, Maressa A.
    Lee, Chee K.
    Chueh, Anderly C.
    Williams, David S.
    Weickhardt, Andrew J.
    Wilson, Kate
    Scott, Andrew M.
    Simes, John
    Hardingham, Jennifer E.
    Price, Timothy J.
    Mariadason, John M.
    Tebbutt, Niall C.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [49] Molecular basis of VEGFR1 autoinhibition at the plasma membrane
    Chakraborty, Manas Pratim
    Das, Diptatanu
    Mondal, Purav
    Kaul, Pragya
    Bhattacharyya, Soumi
    Das, Prosad Kumar
    Das, Rahul
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [50] Molecular basis of VEGFR1 autoinhibition at the plasma membrane
    Manas Pratim Chakraborty
    Diptatanu Das
    Purav Mondal
    Pragya Kaul
    Soumi Bhattacharyya
    Prosad Kumar Das
    Rahul Das
    Nature Communications, 15
12345